Abstract:BackgroundTuberculosis (TB) is the leading cause of mortality among infectious diseases worldwide. Ninty five percent of TB cases and 98% of deaths due to TB occur in developing countries. Globally, the mortality rate has declined with the introduction of effective anti TB chemotherapy. Nevertheless, some patients with active TB still die while on treatment for their disease. In Ethiopia, little is known on survival and risk factors for mortality among a cohort of TB patients. The objective of the study is to … Show more
“…In agreement with previous studies done in different part of the world, in the present study, older ages, smear negative [12,15] and HIV positive [7,10] pulmonary TB patients were more likely to die than their counter parts.…”
Section: Discussionsupporting
confidence: 82%
“…The overall death rates of TB patients in this study was found to be 82 (9%), which is greater than 3.3 % in Northwest Ethiopia [25], 3.7% in a study done in Addis Ababa [12], 3.6% in Gambella [20] and 2.6% in Southern Ethiopia [8] but slightly lower than a study conducted in Gondar University Hospital [15] with death rate of 10.1%.…”
Section: Discussionmentioning
confidence: 72%
“…To this end, very few studies have reported treatment outcomes of DOTS in different parts of Ethiopia from 2005 to 2013 [7][8][9][10][11][12][13][14][15][16][17][18]. The studies conducted so far in different parts of the country (Southern region, Addis Ababa, Gambella and Northern region) documented different rate of treatment success rates ranging from 29.5% in Gondar, North west Ethiopia [15], to 89.2% in Tigray, Northern Ethiopia [17].…”
Objective: Monitoring of tuberculosis treatment outcome is scarcely done in Ethiopia. This study investigated the outcomes of tuberculosis treatment at Bale Robe Hospital in Oromia, Ethiopia.
Methods:A retrospective analysis of the profile and treatment outcome of all tuberculosis patients registered from September, 2007 to August, 2012 at tuberculosis Clinic was conducted. Patients' socio-demographic, clinical, laboratory and treatment outcomes were were extracted from registration document. Bivariate and multivariate logistic regression was used to determine treatment outcomes predictor variables.
Results:We analyzed treatment outcomes of 916 tuberculosis patients, of which 544 (59.6 %) were males. Of these 180 (19.7%) were cured, 536 (58.5%) were found completed their treatment, while 82 (9%) were died, in addition, 55 (6.0%) and 54 (5.9%) were defaulters and transferred out respectively. Overall, 716 (78.2%) had a successful and 200 (21.8%) a poor treatment outcome. Being female (AOR 1.23, P=0.05), HIV positive (0.48, P<0.001) and new TB patients (AOR 2.17, P=0.002) were significantly associated with treatment outcome. Patients aged ≤ 14 had significantly high treatment success rate (AOR 4.99, P=0.003) followed by 35-44 years (AOR 3.5, P=0.009) and 25-34 years (AOR 2.52, P=0.029). Tuberculosis patients with HIV co-infection (AOR 4.32, P=<0.001), smear negative pulmonary tuberculosis (AOR 2.00, P=0.05) and age ≥ 65 years (AOR 5.50, P=0.03) were more likely to experience death than their counter parts.
Conclusion:The treatment success rate of 78.2% tuberculosis patients was fairly good. However, a high proportion of patients (9%) death and 22.2% of HIV prevalence among TB patients is a serious public health concern that needs to be addressed urgently in the area.
“…In agreement with previous studies done in different part of the world, in the present study, older ages, smear negative [12,15] and HIV positive [7,10] pulmonary TB patients were more likely to die than their counter parts.…”
Section: Discussionsupporting
confidence: 82%
“…The overall death rates of TB patients in this study was found to be 82 (9%), which is greater than 3.3 % in Northwest Ethiopia [25], 3.7% in a study done in Addis Ababa [12], 3.6% in Gambella [20] and 2.6% in Southern Ethiopia [8] but slightly lower than a study conducted in Gondar University Hospital [15] with death rate of 10.1%.…”
Section: Discussionmentioning
confidence: 72%
“…To this end, very few studies have reported treatment outcomes of DOTS in different parts of Ethiopia from 2005 to 2013 [7][8][9][10][11][12][13][14][15][16][17][18]. The studies conducted so far in different parts of the country (Southern region, Addis Ababa, Gambella and Northern region) documented different rate of treatment success rates ranging from 29.5% in Gondar, North west Ethiopia [15], to 89.2% in Tigray, Northern Ethiopia [17].…”
Objective: Monitoring of tuberculosis treatment outcome is scarcely done in Ethiopia. This study investigated the outcomes of tuberculosis treatment at Bale Robe Hospital in Oromia, Ethiopia.
Methods:A retrospective analysis of the profile and treatment outcome of all tuberculosis patients registered from September, 2007 to August, 2012 at tuberculosis Clinic was conducted. Patients' socio-demographic, clinical, laboratory and treatment outcomes were were extracted from registration document. Bivariate and multivariate logistic regression was used to determine treatment outcomes predictor variables.
Results:We analyzed treatment outcomes of 916 tuberculosis patients, of which 544 (59.6 %) were males. Of these 180 (19.7%) were cured, 536 (58.5%) were found completed their treatment, while 82 (9%) were died, in addition, 55 (6.0%) and 54 (5.9%) were defaulters and transferred out respectively. Overall, 716 (78.2%) had a successful and 200 (21.8%) a poor treatment outcome. Being female (AOR 1.23, P=0.05), HIV positive (0.48, P<0.001) and new TB patients (AOR 2.17, P=0.002) were significantly associated with treatment outcome. Patients aged ≤ 14 had significantly high treatment success rate (AOR 4.99, P=0.003) followed by 35-44 years (AOR 3.5, P=0.009) and 25-34 years (AOR 2.52, P=0.029). Tuberculosis patients with HIV co-infection (AOR 4.32, P=<0.001), smear negative pulmonary tuberculosis (AOR 2.00, P=0.05) and age ≥ 65 years (AOR 5.50, P=0.03) were more likely to experience death than their counter parts.
Conclusion:The treatment success rate of 78.2% tuberculosis patients was fairly good. However, a high proportion of patients (9%) death and 22.2% of HIV prevalence among TB patients is a serious public health concern that needs to be addressed urgently in the area.
“…One study in Addis Ababa revealed that body weight at initiation of anti-TB treatment (<35 kg) was a significant risk factor of death during antituberculosis treatment period [28]. This difference may be related to the classification of body weight at initiation of anti-TB treatment; in this study body weight classification is based on WHO standard treatment guideline but a study conducted in Addis Ababa used another type of body weight classification.…”
Background. Tuberculosis remains a major global health problem. It causes ill-health among millions of people each year and ranks alongside the human immunodeficiency virus (HIV) as a leading cause of death worldwide. Purpose. To assess the outcome of tuberculosis treatment and to identify factors associated with tuberculosis treatment outcome. Methods. A five-year retrospective cross-sectional study was employed and data were collected through medical record review. Data were analyzed using SPSS version 16 and binary and multiple logistic regression methods were used. A value of less than 0.05 was considered as statistically significant in the final model. Results. Out of the 1584 pulmonary TB patients (882 males and 702 females) including all age group, 60.1% had successful outcome and 39.9% had unsuccessful outcome. In the final multivariate logistic model, the odds of unsuccessful treatment outcome was higher among patients of weight category 30-39.9 kg (AOR = 1.51, 95% CI: 1.102-2.065) and smear negative pulmonary TB (AOR = 3.204, 95% CI: 2.277-4.509) and extrapulmonary TB (AOR = 3.175, 95% CI: 2.201-4.581) and retreatment (AOR = 6.733, 95% CI: 3.235-14.013) and HIV positive TB patients (AOR = 1.988, 95% CI: 1.393-2.838) and unknown HIV status TB patients (AOR = 1.506, 95% CI: 1.166-1.945) as compared to their respective comparison groups. Conclusion. In this study, high proportion of unsuccessful treatment outcome was documented. Therefore emphasis has to be given for patients with high risk of unsuccessful TB treatment outcome and targeted interventions should be carried out.
“…In this regard, results from studies in Ethiopia ranged from 26% to 94% [8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26]. The previous report of TB defaulter, failure, and death rates in Ethiopia ranged from 0.6% to 18.3% [8][9][10][11][12][13][14][15][16][17][18], 0.2% to 18.6% [8][9][10][11]15], and 2.6% to 10.1% [8-10, 12,15,16,19,20], respectively.…”
Introduction: Treatment outcome is an important indicator of tuberculosis control programs, as suggested by the World Health Organization. However, this has not been well documented in the study area. This work contributes to a better understanding this issue. Methodology: A five-year (2009-2013) retrospective cohort study was conducted between April and May 2014, in six randomly selected health institutions providing tuberculosis treatment in western Ethiopia. Bivariate and multivariate logistic regression analyses were used to assess the association between treatment outcomes and predictor variables. Results: A total of 1,175 tuberculosis patients with a mean (standard deviation) age of 29.91 (13.99) were involved in the study. The majority of the study participants had smear-negative pulmonary tuberculosis (39.7%) and extrapulmonary tuberculosis (39.7%). Of all the study participants, 14.5% were cured, 56.3% completed treatment, 0.2% had treatment failure, 8.1% died during follow-up, 7.1% were reported as defaulters, and 13.8% were transferred out to another health institution. The overall treatment success rate was 70.8% and show progressive increases over the course of the study. The associated predictors were enrollment years, HIV co-infection, and sputum smear follow-up in the second, fifth, and seven months. Conclusions: The treatment success rate was unsatisfactory in spite of improvement seen over the study period. Thus, continued follow-up of patients, with frequent supportive supervision during the course of treatment, and provision of early detection and follow-up for HIV infection need to be strengthened to achieve an effective treatment outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.